IGSF3 Monoclonal Antibody (AN200212P)
For research use only.
| Verified Samples |
Verified Samples in IHC: Human placenta, Human kidney Verified Samples in FCM: A549 |
| Dilution | IHC-P 1:50-1:200, FCM 1:25-1:100 |
| Isotype | IgG2a |
| Host | Mouse |
| Reactivity | Human |
| Applications | IHC-P, FCM |
| Clonality | Monoclonal |
| Immunogen | Recombinant Human IGSF3 protein |
| Abbre | IGSF3 |
| Synonyms | IGSF, KIAA, EWI, IGSF3, EWI-3, LCDD, V8, EWI3, KIAA0466 |
| Swissprot | |
| Tissue Specificity | Expressed in a wide range of tissues with High expression in Placenta, kidney and lung. |
| Concentration | 1 mg/mL |
| Buffer | 0.2 μm filtered solution in PBS |
| Purification Method | Protein A |
| Clone No. | A1064 |
| Conjugation | Unconjugated |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
| Shipping | Ice bag |
| background | The protein encoded by this gene is an immunoglobulin-like membrane protein containing several V-type Ig-like domains. A mutation in this gene has been associated with bilateral nasolacrimal duct obstruction (LCDD). |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
-
IF：{{item.impact}}
Journal：{{item.journal}} ({{item.year}})
DOI：{{item.doi}}Reactivity：{{item.species}}
Sample Type：{{item.sample_type}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
